Literature DB >> 31217211

Case of trileaflet mitral valve: an important differential for non-classical intracavitary gradient in suspected hypertrophic cardiomyopathy.

Joseph Barker1, Neil Silverwood1, Robert Gerber1.   

Abstract

There are nine published reports of trileaflet mitral valves globally. As such their implication on health outcomes and associations with other disease is uncertain. This case describes a 62-year-old man presenting with exertional dyspnoea and hypertension. It describes an early misdiagnosis of hypertrophic cardiomyopathy and highlights that clinicians should be alerted in cases of very high left ventricular outflow gradients in the presence of eccentric mitral regurgitation (MR). Here the MR was caused by a rare congenital deformity whereby a deep cleft in the posterior leaflet resulted in a tricuspid appearance. We present the natural disease course of a trileaflet mitral valve and without intervention over 13 years from symptom onset to the development of severe MR. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  clinical diagnostic tests; interventional cardiology; valvar diseases

Mesh:

Year:  2019        PMID: 31217211      PMCID: PMC6586205          DOI: 10.1136/bcr-2018-229106

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Tri-leaflet mitral valve in combination with hypertrophic cardiomyopathy.

Authors:  Richard Bruce Irwin; Anita Macnab; Matthias Schmitt
Journal:  Eur Heart J       Date:  2010-10-10       Impact factor: 29.983

2.  Tri-leaflet mitral valve variant of hypertrophic obstructive cardiomyopathy: Comprehensive assessment with 3-D transesophageal echocardiography.

Authors:  Thomas Butler; Catherina Tjahjadi; Dong Kang; Darryl J Burstow; John F Sedgwick
Journal:  Int J Cardiol       Date:  2015-08-23       Impact factor: 4.164

Review 3.  The Trileaflet Mitral Valve.

Authors:  Jason Chui; Robert H Anderson; Roberto M Lang; Wendy Tsang
Journal:  Am J Cardiol       Date:  2017-11-28       Impact factor: 2.778

4.  'Tri-leaflet mitral valve morphology': a new phenotypic expression in hypertrophic cardiomyopathy?

Authors:  José-Luis Moya-Mur; Ana García-Martín; José Julio Jiménez-Nacher; Covadonga Fernández-Golfín; José-Luis Zamorano-Gómez
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-18       Impact factor: 6.875

5.  MitraClip procedure for the treatment of a pseudo-cleft in the posterior mitral leaflet.

Authors:  Can Öztürk; Robert Schueler; Nikos Werner; Georg Nickenig; Christoph Hammerstingl
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-08-11       Impact factor: 6.875

6.  MitraClip repair of a "trileaflet" regurgitant mitral valve.

Authors:  Xavier Freixa; Doug Hayami; Arsène Basmadjian; Anita W Asgar
Journal:  EuroIntervention       Date:  2015-07       Impact factor: 6.534

7.  Cleft posterior mitral leaflet resembling a tri-leaflet mitral valve: a novel phenotypic association with hypertrophic cardiomyopathy.

Authors:  Hayan Jouni; Steven L Driver; Maurice Enriquez-Sarano; Hector I Michelena
Journal:  Eur Heart J       Date:  2014-02-12       Impact factor: 29.983

8.  Isolated Cleft of the Posterior Mitral Valve Leaflet: The Value of 3DTEE in the Evaluation of Mitral Valve Anatomy.

Authors:  Cláudio Guerreiro; Conceição Fonseca; José Ribeiro; Ricardo Fontes-Carvalho
Journal:  Echocardiography       Date:  2016-04-26       Impact factor: 1.724

9.  Trileaflet Mitral Valve Treated with the MitraClip® System.

Authors:  Miguel Rodríguez-Santamarta; Rodrigo Estévez-Loureiro; Tomás Benito-González; Javier Gualis; Carmen Garrote; Armando Pérez de Prado; Felipe Fernández-Vázquez
Journal:  J Heart Valve Dis       Date:  2017-09

10.  Trileaflet Mitral Valve with Three Papillary Muscles Associated with Hypertrophic Cardiomyopathy: A Novel Case.

Authors:  Salvatore Rosanio; Cameron J Simonsen; John Starwalt; Abdul M Keylani; Antonio Vitarelli
Journal:  Echocardiography       Date:  2015-03-25       Impact factor: 1.724

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.